EAACI Congress 2023
BackFlash talks on allergen immunotherapy II
Saturday 10 Jun, 08:30 AM -
10:00 AM CEST
Hall Y 11+12
Flash Talks
08:30
Non-interventional studies with the SQ grass, tree, ragweed, and house dust mite SLIT-tablets – a systematic literature review
08:37
House dust mite sublingual allergen immunotherapy tablet is safe and well tolerated in Dutch daily practice
08:44
Juniperus oxycedrus pollen allergoid immunization in mice induces humoral and cellular immune responses against natural group 1 allergens from several Cupressacea species
08:51
Prevalence of Cypress pollen sensitization and its clinical relevance in the north of Portugal
08:58
Sensitization to Cupressaceae in Portugal – a multicentric study
09:05
Sublingual immunotherapy with dust mite tablet was successfully introduced and effective in preschoolers with allergic rhinitis: A pilot study
09:12
The clinical usefulness of spit-out method in house dust mite sublingual immunotherapy
09:19
The SQ SLIT-tablets significantly improve quality of life with consistent improvements across ocular and nasal dimensions in adults with grass, tree, ragweed and house dust mite allergic rhinitis (AR)
09:26
Pollen sensitization profiles in a cohort of German allergic patients
09:33
Sensitization to dog and cat allergen components in a cohort of German allergic patients
09:40
Depigmented-polymerized Phleum pratense and Grass-mix extracts are similar in their tolerogenic capacity for use in Allergen-Specific Immunotherapy Treatments
09:47
In vivo safety and efficacy of a plant-made monoclonal antibody for atopic dermatitis treatment
